Healthcare Services

Global Vascular Dementia Industry Trends and Market Growth Forecast for 2026–2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Vascular Dementia Market Over The Period 2026–2030?

The vascular dementia market size has observed substantial growth in recent years. It is anticipated to expand from $3.27 billion in 2025 to $3.65 billion in 2026, at a compound annual growth rate (CAGR) of 11.8%. The expansion during the historic period can be attributed to increasing incidence of stroke-related cognitive decline, rising prevalence of hypertension and diabetes, expansion of neurological research programs, improved diagnostic awareness, and growth in hospital-based dementia care.

The vascular dementia market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $5.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. This growth during the forecast period is primarily driven by factors such as a continuously increasing aging population, a surge in investments aimed at neurological drug development, the wider adoption of digital health monitoring solutions, the broadening application of precision medicine strategies, and an intensified focus on managing long-term cognitive health. Prominent trends expected in this period include a heightened emphasis on the early diagnosis of cognitive disorders, the growing integration of digital tools for cognitive assessment, increased research into neurodegeneration associated with vascular conditions, the expansion of personalized treatment methods, and a stronger commitment to preventive care approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Which Economic Or Industry Drivers Are Impacting The Vascular Dementia Market?

The increasing incidence of cardiovascular disease is anticipated to boost the vascular dementia market moving forward. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. The growing occurrence of cardiovascular diseases is influenced by elements like unhealthy lifestyles, poor dietary habits, physical inactivity, heightened stress levels, aging populations, and an escalation in risk factors such as obesity, diabetes, and hypertension. These heart conditions elevate the risk of vascular dementia by hindering blood flow to the brain, leading to cognitive decline and damage to brain cells due to insufficient oxygen and nutrient supply. For instance, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, amounting to over 170,000 deaths annually, or roughly 480 deaths each day, which signifies one death every three minutes. Consequently, the rising prevalence of cardiovascular diseases is a significant driver for the vascular dementia market.

How Is The Vascular Dementia Market Divided Into Its Major Segments?

The vascular dementia market covered in this report is segmented –

1) By Product: Small Molecules / Drugs, Lifestyle And Nutraceutical Interventions, Rehabilitation Therapies

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:

1) By Small Molecules Or Drugs: Antihypertensives, Anti-diabetic agents, Lipid-lowering agents, Anti-inflammatory agents, Neuroprotective small molecules

2) By Lifestyle And Nutraceutical Interventions: Vitamins & Supplements, Omega-3 Or DHA formulations, Antioxidants

3) By Rehabilitation Therapies: Cognitive enhancers, Physical therapy programs, Occupational therapy aids

What Trends Are Advancing Progress In The Vascular Dementia Market?

Major companies operating in the vascular dementia market are concentrating on developing innovative therapies, such as multimodal treatments, to retain their market position. Multimodal therapies entail the integration of various treatment methods, including medications, physical therapy, and psychological interventions, to provide comprehensive care for a condition. For instance, in January 2023, Moleac, a Singapore-based biopharmaceutical company, launched CognivAiD, an evidence-based treatment specifically tailored for vascular dementia (VaD), a condition with limited therapeutic choices. This product combines active extracts from ginkgo, ginseng, and saffron, which have demonstrated a significant slowing of cognitive decline in VaD patients. The unique multimodal action of CognivAiD targets key mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Supported by extensive clinical trials and a strong safety profile, CognivAiD offers a promising new treatment for individuals suffering from VaD.

Who Are The Prominent Organizations Shaping The Vascular Dementia Market?

Major companies operating in the vascular dementia market are Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix Corp, Cyclerion Therapeutics Inc, CSPC-NBP Pharma, Johnson & Johnson Services Inc, Materia Medica Holding, Eisai Co Ltd, Shineway Pharmaceutical, Merz Pharma, Ever Neuro Pharma GmbH, Zhejiang Otsuka Pharma, Pfizer Inc, Biogen Inc, Novartis AG, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals, Zydus Cadila, Eli Lilly and Company

Read the full vascular dementia market report here:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What Are The Top-Performing Regions Within The Vascular Dementia Market?

North America was the largest region in the vascular dementia market in 2025. The regions covered in the vascular dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vascular Dementia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

Browse Through More Reports Similar to the Global Vascular Dementia Market 2026, By The Business Research Company

Peripheral Artery Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Vascular Imaging Global Market Report

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795